subscribe: Posts | Comments | Email

SAP Supplier InfoNet- An Impressive Application with Lots of Potential to Mitigate Supply Chain Risk

0 comments

This posting is an update to our previous Supply Chain Matters commentary regarding Ariba, an SAP Company and its announced availability of a new application targeted for supply chain risk management.  As we indicated in that original posting, Supply Chain Matters does not elect to echo technology vendor announcements unless we believe it should capture the attention of our readers, and we get the opportunity to drill down on the specifics and functionality. Ariba teamed up with SAP Supplier InfoNet, an internal incubation business unit to provide availability of this cloud-based application. We have since received a detailed briefing on the functionality of this application, and candidly, we were impressed, for a number of reasons. First, the application itself is not solely targeted to just a sourcing and procurement user base, but other cross-functional users that have responsibility related to broad-based supply chain disruption and risk mitigation. Supply Chain Matters […]


P&G Selling Bulk of its Pet Food Business to Mars- A Supply Chain Leverage Opportunity

0 comments

Supply Chain Matters would venture a guess that many of our readers are under the impression that privately held Mars, Inc, the producer of delicious M&M chocolates and Snickers candy bars was primarily a candy and snacks provider. Not so. Mars Pet Care Division which includes brands such as Pedigree and Whiskas is, according to the Wall Street Journal, this company’s largest and fastest-growing division. Thus, yesterday’s announcement that Procter & Gamble is selling the bulk of its pet food business, with brands such as Eukanuba, Iams and Natura, to Mars is a rather significant development. The value of the deal is estimated to be $2.9 billion, but it does not include distribution of brands in the European Union.  The transaction is expected to close in the second half of 2014. Reuters and other business media reports have indicated that P&G’s current multi-year restructuring program called for the exit of […]


Product Recalls Among Two Automotive OEM’s- Which is the More Significant?

0 comments

General and business media has provided much amplification of the latest product recall troubles involving General Motors. In the past few weeks GM has recalled upwards of 6.3 million vehicles globally for quality issues related to faulty ignition switches, a sudden loss of electric power-steering assistance and other issues. The incidents have once again raised issues as to why certain automotive manufacturers allow quality conformance issues regarding products to fester until consumers experience the results of such non-conformance, or in some cases suffer personal injury or death. The GM crisis has been billed as the first test of the leadership of newly appointed CEO Mary Barra, who just happens to have a supply chain, product and operations management career background prior to assuming her new top leadership role.  Indeed this latest crisis might have been the legacy handed over from previous GM CEO’s. Given Ms. Barra’s background, Supply Chain Matters […]


India Based Ranbaxy Laboratories Acquired- Quality Conformance Remains an Issue

0 comments

Supply Chain Matters has featured multiple commentaries citing India based generic drug producer Ranbaxy Laboratories. Our latest commentaries were in a specific posting in late January and in an India based industry regulatory commentary published in February. Thus, we were not at all surprised with this week’s announcement that Japan based Daiichi Sanko Co. the parent of Ranbaxy, has agreed to sell the generic drug manufacturer to India based Sun Pharmaceutical Industries Ltd. in a deal reported to be valued at $3.2 billion in a mostly stock-based deal. This transaction is expected to be completed by the end of the year. The U.S. market accounts for a significant amount of Ranbaxy’s current revenues, while the U.S. Food and Drug Administration (FDA) currently bars imports from four out of five Ranbaxy production facilities in India due to inspectional findings. According to a report published by the Wall Street Journal, after a […]


Supply Chain Matters Highlights of the MIT 2014 Crossroads Conference

1 comment

Supply Chain Matters had the opportunity to recently attend the 2014 Crossroads Conference hosted by the Massachusetts Institute of Technology (MIT) Center for Transportation and Logistics (CTL). Crossroads is an event that began 10 years ago, and each year we look forward to attending and hearing about leading-edge trends and developments in MIT supply chain focused research and across industry supply chains. Each year, the agenda shifts in focus and the 2014 conference featured talks on advanced and emerging research occurring among select MIT faculty members.  The conference was kicked-off with a presentation from MIT Professor Suzanne Berger, principal author of the book, Making in America, From Innovation to Market. Professor Berger summarized the multi-year research conducted by the MIT Task Force on Production and Innovation. Supply Chain Matters has previously posted our summary of last year’s event that reported on the findings from the MIT PIE Task Force. None […]


Supply Chain Matters Attendance at 2014 Oracle Industry Connect Conference

0 comments

Supply Chain Matters was invited to attend Oracle’s Industry Connect Conference held in Boston at the latter part of March. The conference drew a large compliment of attendees, featured three industry tracts, along with a focus on program management.  We enjoy attending industry focused events because they provide a keener sense of industry-specific challenges, viewpoints and perspectives.  We encourage technology and services providers to host more such events. Due to a commitment to attend another event, we devoted the majority of our limited time focused on the Retail industry tract of speakers, but did manage to catch a cross-industry panel discussion featuring the theme of the Customer Experience. One clear theme brought out by this panel was that nearly every industry sector is adjusting to more demanding and more personalized experience factors concerning customers. Healthcare consumers now have many more choices for an healthcare provider and with a new emphasis […]


« Previous Entries